Bio-Rad Laboratories (NYSE:BIO.B) Hits New 12-Month High – Here’s What Happened

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) hit a new 52-week high during trading on Thursday . The company traded as high as $359.22 and last traded at $357.65, with a volume of 326 shares trading hands. The stock had previously closed at $357.05.

Bio-Rad Laboratories Price Performance

The stock has a market capitalization of $10.01 billion, a PE ratio of -13.09 and a beta of 0.72. The company has a debt-to-equity ratio of 0.16, a current ratio of 6.14 and a quick ratio of 4.52. The firm’s 50 day simple moving average is $336.01 and its 200 day simple moving average is $328.84.

Bio-Rad Laboratories (NYSE:BIO.B) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $2.01 earnings per share for the quarter. Bio-Rad Laboratories had a negative net margin of 30.18% and a positive return on equity of 3.74%. The business had revenue of $649.73 million during the quarter.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.